UVA Hyperspectral Light-Sheet Microscopy for Volumetric Metabolic Imaging: Application to Preimplantation Embryo Development
Authors:
- Josephine MorizetJMJosephine Morizet
- Darren ChowDCDarren Chow
- Philip WijesinghePWPhilip Wijesinghe
- Erik SchartnerErik Schartner
- George DwapanyinGDGeorge Dwapanyin
- Nicolas DubostNDNicolas Dubost
- Graham D. BruceGBGraham D. Bruce
- Ellen AnckaertEAEllen Anckaert
- Kylie DunningKDKylie Dunning
- Kishan DholakiaKDKishan Dholakia
Open Access
- 13 November 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Photonics
- Vol. 10 (12) , 4177-4187
Abstract
Cellular metabolism is a key regulator of energetics, cell growth, regeneration, and homeostasis. Spatially mapping the heterogeneity of cellular metabolic activity is of great importance for unraveling the overall cell and tissue health. In this regard, imaging the endogenous metabolic cofactors, nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and flavin adenine dinucleotide (FAD), with subcellular resolution and in a noninvasive manner would be useful to determine tissue and cell viability in a clinical environment, but practical use is limited by current imaging techniques. In this paper, we demonstrate the use of phasor-based hyperspectral light-sheet (HS-LS) microscopy using a single UVA excitation wavelength as a route to mapping metabolism in three dimensions. We show that excitation solely at a UVA wavelength of 375 nm can simultaneously excite NAD(P)H and FAD autofluorescence, while their relative contributions can be readily quantified using a hardware-based spectral phasor analysis. We demonstrate the potential of our HS-LS system by capturing dynamic changes in metabolic activity during preimplantation embryo development. To validate our approach, we delineate metabolic changes during preimplantation embryo development from volumetric maps of metabolic activity. Importantly, our approach overcomes the need for multiple excitation wavelengths, two-photon imaging, or significant postprocessing of data, paving the way toward clinical translation, such as in situ, noninvasive assessment of embryo viability.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/P030017/1, EP/R004854/1)
- Hospital Research Foundation (C-MCF-58-2019)
- University of Adelaide
- National Health and Medical Research Council (APP2003786)
- Australian Research Council (FL210100099)
- Horizon 2020 Framework Programme (871212, EC-GA 863203)
This publication has 40 references indexed in Scilit:
- Quantitative Optical Imaging of Primary Tumor Organoid Metabolism Predicts Drug Response in Breast CancerCancer Research, 2014
- The potential of label-free nonlinear optical molecular microscopy to non-invasively characterize the viability of engineered human tissue constructsBiomaterials, 2014
- Light-sheet microscopy using an Airy beamNature Methods, 2014
- Non-invasive monitoring of cell metabolism and lipid production in 3D engineered human adipose tissues using label-free multiphoton microscopyBiomaterials, 2013
- Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast CancerCancer Research, 2013
- Light sheet microscopy for real-time developmental biologyCurrent Opinion in Genetics & Development, 2011
- In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epitheliaProceedings of the National Academy of Sciences, 2007
- Towards metabolic mapping of the human retinaMicroscopy Research and Technique, 2007
- Three‐dimensionally resolved NAD(P)H cellular metabolic redox imaging of the in situ cornea with two‐photon excitation laser scanning microscopyJournal of Microscopy, 1995
- Ultraviolet confocal fluorescence microscopy of the in vitro cornea: redox metabolic imagingApplied Optics, 1993